Furthermore, RBM5 antisense (RBM5-AS1) directly associates with β-catenin and facilitates the recruitment of β-catenin and TCF4 complex to the WNT target genes SGK1, YAP1, and MYC, activating the WNT pathway in CRC [146]. Here, RBM5 is linked to colorectal carcinoma.